The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post–COVID-19 Syndrome in Healthcare Workers
Christopher Pereira, Benjamin Harris, Matteo Di Giovannantonio, Carolina Rosadas, Charlotte‐Eve Short, Rachael Quinlan, Macià Sureda-Vives, Natalia Fernández, Isaac Day-Weber, Maryam Khan, Federica Marchesin, Ksenia Katsanovskaja, Eleanor Parker, Graham P. Taylor, Richard S. Tedder, Myra O. McClure, Melanie Dani, Michael Fertleman
Abstract
It is currently unknown how post-COVID-19 syndrome (PCS) may affect those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This longitudinal study includes healthcare staff who tested positive for SARS-CoV-2 between March and April 2020, with follow-up of their antibody titers and symptoms. More than half (21 of 38) had PCS after 7-8 months. There was no statistically significant difference between initial reverse-transcription polymerase chain reaction titers or serial antibody levels between those who did and those who did not develop PCS. This study highlights the relative commonality of PCS in healthcare workers and this should be considered in vaccination scheduling and workforce planning to allow adequate frontline staffing numbers.